These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 17895474)

  • 1. Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence.
    Haas GP; Delongchamps NB; Jones RF; Chandan V; Serio AM; Vickers AJ; Jumbelic M; Threatte G; Korets R; Lilja H; de la Roza G
    J Natl Cancer Inst; 2007 Oct; 99(19):1484-9. PubMed ID: 17895474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
    Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
    J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive predictive value of high-grade prostatic intraepithelial neoplasia in initial core needle biopsies of prostate adenocarcinoma--a study with complete sampling of hemi-prostates with corresponding negative biopsy findings.
    Delatour NL; Mai KT
    Urology; 2008 Sep; 72(3):623-7. PubMed ID: 18279923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
    Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
    Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen.
    Delongchamps NB; de la Roza G; Chandan V; Jones R; Threatte G; Jumbelic M; Haas GP
    Prostate Cancer Prostatic Dis; 2009; 12(2):137-42. PubMed ID: 18626509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of prostate cancer via biopsy in the Medicare-SEER population during the PSA era.
    Welch HG; Fisher ES; Gottlieb DJ; Barry MJ
    J Natl Cancer Inst; 2007 Sep; 99(18):1395-400. PubMed ID: 17848671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anterior apical biopsy: is it useful for prostate cancer detection?
    Orikasa K; Ito A; Ishidoya S; Saito S; Endo M; Arai Y
    Int J Urol; 2008 Oct; 15(10):900-4; discussion 904. PubMed ID: 18657203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating localized prostate cancer and identifying candidates for focal therapy.
    Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
    Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic transition zone directed needle biopsies uncommonly sample clinically relevant transition zone tumors.
    Haarer CF; Gopalan A; Tickoo SK; Scardino PT; Eastham JA; Reuter VE; Fine SW
    J Urol; 2009 Oct; 182(4):1337-41. PubMed ID: 19683261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection bias due to the effect of finasteride on prostate volume: a modeling approach for analysis of the Prostate Cancer Prevention Trial.
    Cohen YC; Liu KS; Heyden NL; Carides AD; Anderson KM; Daifotis AG; Gann PH
    J Natl Cancer Inst; 2007 Sep; 99(18):1366-74. PubMed ID: 17848668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
    Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
    Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined prostate-specific antigen density and biopsy features to predict "clinically insignificant" prostate cancer.
    Loeb S; Roehl KA; Thaxton CS; Catalona WJ
    Urology; 2008 Jul; 72(1):143-7. PubMed ID: 18436287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of prostate cancer on first re-biopsy within 1 year following a diagnosis of high grade prostatic intraepithelial neoplasia is related to the number of cores sampled.
    Herawi M; Kahane H; Cavallo C; Epstein JI
    J Urol; 2006 Jan; 175(1):121-4. PubMed ID: 16406886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of lateral biopsy specimens during transrectal ultrasound-guided prostate biopsies in Japanese men.
    Shigemura K; Arakawa S; Yamanaka K; Kataoka N; Yuien K; Fujisawa M
    Int J Urol; 2007 Oct; 14(10):935-8. PubMed ID: 17880293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance.
    Nakanishi H; Groskopf J; Fritsche HA; Bhadkamkar V; Blase A; Kumar SV; Davis JW; Troncoso P; Rittenhouse H; Babaian RJ
    J Urol; 2008 May; 179(5):1804-9; discussion 1809-10. PubMed ID: 18353398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.
    Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW
    Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A nomogram for predicting low-volume/low-grade prostate cancer: a tool in selecting patients for active surveillance.
    Nakanishi H; Wang X; Ochiai A; Trpkov K; Yilmaz A; Donnelly JB; Davis JW; Troncoso P; Babaian RJ
    Cancer; 2007 Dec; 110(11):2441-7. PubMed ID: 17932909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laterally directed biopsies detect more clinically threatening prostate cancer: computer simulated results.
    Kawata N; Miller GJ; Crawford ED; Torkko KC; Stewart JS; Lucia MS; Miller HL; Hirano D; Werahera PN
    Prostate; 2003 Oct; 57(2):118-28. PubMed ID: 12949935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimal sampling sites for repeat prostate biopsy: a recursive partitioning analysis of three-dimensional 26-core systematic biopsy.
    Kawakami S; Okuno T; Yonese J; Igari T; Arai G; Fujii Y; Kageyama Y; Fukui I; Kihara K
    Eur Urol; 2007 Mar; 51(3):675-82; discussion 682-3. PubMed ID: 16843585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.